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a b s t r a c t
Previous studies from our group have demonstrated the high susceptibility of
Toxoplasma gondii tachyzoites to the sterol analogues 22,26-azasterol and 24,25-(R,S)-
epiminolanosterol. In this work we present data on testing in vitro three novel azasterols
as potential agents for the treatment of toxoplasmosis. The three compounds inhibited
parasite growth at micromolar concentrations, in a dose-dependent manner. Electroneywords:
zasterols
oxoplasmosis
hemotherapy
ltrastructure
microscopy analysis of intracellular tachyzoites after treatment with the most effective
compound showed drastic mitochondrion swelling associated with the appearance of an
electron-lucent matrix and disrupted cristae. Parasite lysis also took place. The appear-
ance of electron dense cytoplasmic structures similar to amylopectin granules distributed
throughout the parasite suggests that azasterols might be inducing differentiation of those
were ntachyzoites which
. Introduction
Toxoplasma gondii is an obligate intracellular protozoan
arasite found throughout the world. It infects members
f the Felidae family and a wide range of animals, includ-
ng humans (Tenter et al., 2000). The infection in humans
s usually asymptomatic but can cause great morbidity and
ortality in imunocompromissed or congenitally infected
ndividuals. The disease in sheep is responsible for abor-
ion and neonatal deaths, causing economic losses (Dubey
nd Jones, 2008). The most effective current therapy for
he treatment of toxoplasmosis is the synergistic combina-
ion of pyrimethamine and sulfadiazine, which blocks both
olic acid biosynthesis and folic acid metabolism. Folinic
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acid is added to the regimen to reduce the risk of bone
marrow suppression (Remington et al., 2006). Although
very effective, this treatment is commonly associated with
many adverse effects and has no efﬁcacy against tissue
cysts, leading to the possibility of recurrence after treat-
ment (Montoya and Liesenfeld, 2004). Thus the search for
new chemotherapeutic drugs for the treatment of toxo-
plasmosis is very important.
Azasterols, initially developed as inhibitors of the sterol
biosynthesis enzyme 24(25)-sterol methyl transferase
(SMT), have been shown to have activity againstmany pro-
tozoan parasites, including Trypanosoma cruzi, Leishmania
sp. (Rodrigues et al., 2002; Magaraci et al., 2003; Gros et al.,
2006a) and Giardia lamblia (Maia et al., 2007). Although
T. gondii lacks the sterol biosynthetic pathway (Coppens
Open access under the Elsevier OA license.et al., 2000) two azasterols, inhibitors of the enzyme SMT,
were able to inhibit proliferation of T. gondii and induce
several ultrastructural changes (Dantas-Leite et al., 2004).
The mode of action of the azasterols against T. gondii is still
unknown. In this report, we present data for three novel
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Table 1
Growth inhibition of T. gondii by azasterol analogues after 24 and 48h of
treatment.a
IC50 (M)
Compound Structure 24h 48h
1 >5 4.7±1.7
2 3.8±1.2 3.1±0.7
3 2.6±0.2 0.80±0.5a Results are expressed as mean± standard error of three different
experiments.
azasterols which showed selective activity against T. gondii
in infected LLC-MK2 cells.
2. Methodology
Tachyzoites from the virulent RH strain of T. gondii, iso-
lated from human brain (Sabin, 1941) were used in the
in vitro experiments and were maintained by intraperi-
toneal (i.p.) passages in Swiss mice. The cystogenic Me49
strain of T. gondii, was isolated from sheep (Lunde and
Jacobs, 1983), and was used as a control for the carbohy-
drate detection experiments.
Preparation of compounds 1–3 has previously been
described (Magaraci et al., 2003; Lorente et al., 2005). Com-
pound 1 is compound 9b in the original reference (Lorente
et al., 2005); compound 3 is compound 3c (Lorente et al.,
2005); and compound 2 is compound 10 (Magaraci et al.,
2003). The compounds were dissolved in dimethyl sulfox-
ide (DMSO) (Merck KGaA, Darmstadt, Germany) and added
directly to the growth medium; the ﬁnal concentration of
DMSO in themediumnever exceeded 0.1% (v/v) and hadno
effect either on the proliferation of intracellular parasites
or on the host cells (data not shown).
LLC-MK2 cell cultures (kidney, Rhesus monkey, Macaca
mulata – ATCC CCL7, Rockville, MD/EUA) were main-
tained in RPMI medium with 5% fetal bovine serum (FBS)
at 37 ◦C in an atmosphere of 5% CO2. For the in vitro
anti-proliferative assays approximately 5×105 cells were
cells placed in a 24-well tissue culture plate one day
before. The cells were infected with freshly obtained par-
asites, re-suspended in RPMI without fetal bovine serum
(FBS) at a ratio of 3:1 parasite/host cell. Tachyzoites were
allowed to interact for 1h and then the cell monolayers
were washed twice with phosphate-buffered saline (PBS)
to remove non-adherent extracellular parasites. Differentrasitology 177 (2011) 157–161
concentrations of azasterols were added to the infected
cells 6h after infection and incubated for 24 or 48h at
37 ◦C (assays were performed in triplicate). The parasite
proliferation was evaluated using selective [5,6-3H] uracil
incorporationby theparasites (Pfefferkorn andPfefferkorn,
1977). Thus, after treatment, 0.2Ci of [5,6-3H]uracil/well
(speciﬁc activity 42Ci/mmol; Amersham Biosciences UK
Limited) was added to the infected cultures and incubated
for an additional 4h. Uracil incorporation by parasites was
evaluated by liquid scintillation andwas carried out as pre-
viously described (Martins-Duarte et al., 2008). For IC50
(concentration for 50% parasite growth inhibition) calcu-
lations, the percentage of growth inhibition was plotted as
a function of the drug concentration by ﬁtting the values
to non-linear curve analysis. The regression analyses were
performed using Sigma Plot 8.0 software (Systat Software
Inc., Chicago, IL, USA).
Morphological changes induced by the compounds on
the ultrastructure of T. gondii tachyzoites were examined
by transmission electron microscopy. For these experi-
ments LLC-MK2 cultures were infected with tachyzoites
at a ratio of 5:1 parasites/host cell. Infected cells (controls
or treated with the azasterols) were ﬁxed with 2.5% glu-
taraldehyde in 0.1M sodium cacodylate buffer (pH 7.4).
Cells were post-ﬁxed for 1h in the dark with a solution
containing 1% osmium tetroxide, 1.25% potassium ferro-
cyanide and 5mMCaCl2, in 0.1M sodium cacodylate buffer
(pH 7.4). Samples were dehydrated with increasing con-
centrations of acetone, and then embedded in PolyBed
(Polyscience Inc., Warrington, PA, USA). Ultrathin sections
were stained with uranyl acetate and lead citrate and then
observed using a Zeiss 900 Electron Microscope (Carl Zeiss,
Inc.).
For detection of polysaccharide inclusions, ultrathin
sections of samples prepared for transmission electron
microscopy, as described above, were processed for cyto-
chemical detection of carbohydrates (Thiéry, 1967). Tissue
cysts were used as a positive control for amylopectin gran-
ules. Cysts were obtained from mice previously infected
with T. gondii strain Me49 for at least 4 weeks, based on
the protocol established by Freyre (1995). Ultrathin sec-
tions collected on 200-mesh gold grids were incubated in
1% periodic acid for 30min, washed in distilled water and
incubated with 1% thiosemicarbazide in 10% acetic acid
for 72h. Next, the sections were washed in 10%, 5% and
2% acetic acid and 3 times in distilled water for 10min.
Afterwards, the sectionswere incubated for 30minwith 1%
silver proteinate in the dark andwashed abundantly in dis-
tilled water. For control assays, periodic acid was omitted.
The sections were observed in a Jeol 1200 EX transmission
electron microscope operating at 80kV.
For imunoﬂuorescence assays, LLC-MK2 cells infected
with tachyzoites at a ratio of 3:1 parasite/host cell were
treated with compounds 1, 2 or 3 for 48h. At the end of
treatment, infected cells were ﬁxed in 3.7% freshly pre-
pared formaldehyde, permeabilizedwith0.5%TritonX-100
for 15min and blocked with 3% bovine serum albumine in
PBS pH 7.4 for 1h at room temperature. Cells were then
incubated for 1h in the presence of Dolichos biﬂorus lectin
conjugated with FITC (DBA-FITC) 10g/ml (Sigma–Aldrich
Co., St. Louis, MO, USA). After lectin labeling, the coverslips
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Fig. 1. Effect of azasterol treatment in the ultrastructure of T. gondii-infected LLC-MK2 (A) T. gondii tachyzoites in the absence of treatment, showing the
characteristic features of parasite morphology. C: conoid, Rp: rhoptry, DG: dense granule, A: apicoplast, M: mitochondrion, N: nucleus. (B) Swelling of T.
gondii mitochondrion (M) and the appearance of electron-dense structures in the cytoplasm (*) can be observed after treatment with 3M compound
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wfor 48h. (C) A large vacuole (arrowhead) can be seen in one of the ta
mylopectin-like structures (*) can also be seen. (D) Lyses of a tachyzoit
arrow). PV: parasitophorous vacuole, HC: host cell. Bars =500nm.
ere mounted and observed in a Zeiss Axioplan micro-
cope using the ﬂuorescein ﬁlters.
. Results and discussion
The azasterols inhibited T. gondii proliferation with IC50
alues in the micromolar range. Table 1 shows the in vitro
nti-proliferative activity of the azasterols. Compound 3
as the most active, showing an IC50 at nanomolar range
fter 48h. The anti-proliferative activity range of the new
ompounds (0.8–4.7M) was of the same order as that
ig. 2. Electron micrographs showing polysaccharide granules after treatment of
yst containing bradyzoites showing several amylopectin granules (white arrows)
f the granules. (B) Bradyzoite processed for the detection of polysaccharide granu
ith 3M compound 3 and processed for Thiéry technique. Polysaccharide granues after treatment with 3M compound 3 for 48h. The appearance of
reatment with 3M compound 3 for 48h. The conoid can be identiﬁed
previously obtained by our group for 22,26-azasterol and
24,25-(R,S)-epiminolanosterol (Dantas-Leite et al., 2004).
These results conﬁrm that azasterols can cause growth
inhibition of T. gondii, across a variety of different structural
types. Interestingly, compounds do not necessarily need to
have a basic nitrogen as can be seen from compounds 2 and
3, which has implications for the mode of action.
In order to investigate the selective effect of the aza-
sterols against T. gondii over host cell, LLC-MK2 cell
monolayers were treated for 48h with the compounds at
concentrations ﬁve times higher than the IC50 obtained
infected cells with 3M compound 3 for 48h. (A) Control preparation of
in the parasite cytoplasm. Cystwall (asterisk). Inset: highermagniﬁcation
les (black arrows) following the Thiery technique. (C) Tachyzoite treated
les (black arrows). Bars =500nm.
160 É.S. Martins-Duarte et al. / Veterinary Parasitology 177 (2011) 157–161
A-FITC
horous
TC.Fig. 3. Fluorescence microscopy of tachyzoites of T. gondii stained with DB
compound 3 (C). Treatment with azasterol led to the staining of parasitop
inducing the formation of cysts. Arrow head: vacuoles stained for DAB-FI
after 48h. The analysis by dye exclusion test with 0.4% Try-
panblue in PBS, demonstrated that only less than5%of cells
treated with azasterols lost their viability. This result was
similar to that obtained for control cells, demonstrating the
selective effect of azasterols on T. gondii over host cells.
Previous toxicity investigation using KB cells also demon-
strated that compounds 1–3 are well-tolerated by animal
cells and selective against protozoan parasites (Magaraci
et al., 2003; Lorente et al., 2005).The morphological changes observed by electron
microscopy demonstrated that compounds 1 and 3 had
similar effects on the parasite, when compared with con-
trol preparations (Fig. 1A), causing:mitochondrial swelling
(Fig. 1B); appearance of large granules (Fig. 1B and C, aster-after treatement with azasterols: control (A), 3M compound 2 (B), 1M
vacuole with DBA-FITC, demonstrating that the compounds are possibly
isks), morphologicaly similar to the amylopectin granules
found in the bradyzoite stage (Fig. 2A); and parasite lysis
(Fig. 1C). The carbohydrate nature of these granular inclu-
sions was conﬁrmed using the technique established by
Thiéry (1967). In this experiment, the tissue cyst brady-
zoites were used as a positive control, as they are known to
contain carbohydrate granules (Fig. 2B). The granules in the
azasterol-treated tachyzoites (Fig. 2C) stained positively
in this assay, conﬁrming that they were of carbohydrate
nature. In a further experiment, azasterol-treated cul-
tures were stained with DBA-FITC (a lectin from Dolichos
biﬂorans) (Fig. 3A–C), which speciﬁcally binds cyst wall
N-acetyl-galactosamine residueswhichare found inbrady-
zoites (Zhang et al., 2001), but not in the tachyzoites
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arasitophorous vacuole. The treatment for 48hwith com-
ounds 2 and 3 in concentrations near to the IC50 led to the
ositive staining of many vacuoles (Fig. 3B and C), indicat-
ng the presence of cysts forming in response to azasterol
reatment.
Taken together, these results suggest that the azas-
erols could possibly induce the conversion of tachyzoites
o bradyzoites. This differentiation to bradyzoite stage
ould be an adaptive response of the parasite to the com-
ounds, as the bradyzoite stage is less susceptible to drugs
Araujo et al., 1991). Thus, tachyzoites that did not suc-
umb to treatmentwith azasterolsmight be differentiating
o bradyzoites as a mechanism to escape lysis. This is
onsistent with previous work that has demonstrated dif-
erentiation to the bradyzoite stage can be stimulated by
rug pressure (Tomavo and Boothroyd, 1995; Gross and
ohl, 1996).
The molecular target for these compounds in T. gondii
s not known; a possible mode of action may be the
imilarity of the sterol core in both azasterols and choles-
erol molecules, leading to indiscriminate uptake of these
ompounds by the parasite. The excess of intracellu-
ar sterol molecules can cause many deleterious effects,
rincipally to membranes (Urbina et al., 1995). Many mor-
hological changes observed in T. gondii by ultrastructural
nalysis are associated with damage to cellular mem-
ranes, such as mitochondrial swelling and rupture of
he parasite plasma membrane. Another possibility, which
eserves further investigation, is that azasterols may have
n effect on methylation during phospholipid biosynthe-
is (Palmié-Peixoto et al., 2006). Similarly, the effect of
zasterols against the bloodstream form of Trypanosoma
rucei rhodesiense, which utilises host sterols (Coppens and
ourtoy, 2000), also demonstrated that, these compounds
an inhibit the growth of these protozoa by a mechanism
f action other than inhibition of ergosterol biosynthesis
Gros et al., 2006b). Our results demonstrate that azasterols
re very active and selective against T. gondii in vitro and
uggest further investigation of this class of molecules as
otential agents against toxoplasmosis.
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